Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FYN89
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,948
Award facts
- Contract value 100% obligated
- $40,947.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $40,947.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 mL vials. The award, issued on April 24, 2025, carries an ultimate completion date of May 15, 2025, and was made without a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, a single-award vehicle valued at $499,999,999 and valid through November 2026, which authorizes firm fixed-price orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in Defense Logistics Agency procurement. The company's portfolio with the agency includes delivery of prescription medications, biologics, vaccines, and specialty pharmaceuticals across oncology, contraceptive, and general medical categories. This particular award for Keytruda, an oncology treatment, reflects the company's continued role in delivering branded pharmaceutical products essential to the Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB25FYN89?
SPE2DB25FYN89 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 24, 2025.
How much is contract SPE2DB25FYN89 worth?
The government has obligated $40,948 on SPE2DB25FYN89.
Is contract SPE2DB25FYN89 an order under another contract?
Yes. SPE2DB25FYN89 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB25FYN89 competed?
The extent of competition for SPE2DB25FYN89 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award